ライフサイエンスコーパス: ipratropium bromide

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ing responsiveness to inhaled salbutamol and ipratropium bromide.

2 ization of a mixture of albuterol 2.5 mg and ipratropium bromide 0.5 mg.

3 ved either salmeterol 42 microg twice daily, ipratropium bromide 36 microg four times daily, or place

4 The subjects were treated with ipratropium bromide (84 microgram) or normal saline solu

5 mpare the effects between pretreatments with ipratropium bromide and placebo aerosols on the airway r

6 Inhaled anticholinergics such as ipratropium bromide (IB), when administered with beta2-a

7 butamol) and a short-acting anticholinergic (ipratropium bromide), in COPD is encouraging because the

8 Our data show that ipratropium bromide increases the ability of the nose to

9 Ipratropium bromide led to less reduction in the cold, d

10 Either 1) ipratropium bromide nasal spray 0.06% in buffered salt s

11 sed it to study the effect of treatment with ipratropium bromide on the ability of the nose to condit

12 of a metered-dose inhaler containing either ipratropium bromide or placebo (two inhalations three ti

13 Inhaled anticholinergics (ipratropium bromide or tiotropium bromide) are widely us

14 Intranasal ipratropium bromide provides specific relief of rhinorrh

15 Thus, treating rhinitis with ipratropium bromide should not increase the burden for i

16 vere exacerbation of asthma, the addition of ipratropium bromide to albuterol and corticosteroid ther

17 Ipratropium bromide treatment significantly increased na

18 Ipratropium bromide was provided as rapid-relief treatme

19 as-needed albuterol use was discontinued and ipratropium bromide was used as needed.

20 ed (1:1) to receive nebulised salbutamol and ipratropium bromide with either 2.5 mL of isotonic MgSO(

21 atment group received 500 microg (2.5 ml) of ipratropium bromide with the second and third doses of a

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。